About Cellipont
Cellipont is a company based in Poway (United States) founded in 2002 was acquired by Great Point Partners in January 2022. Cellipont offers products and services including Clinical Manufacturing, Process Development, Analytical Development, and Allogeneic CAR-T Services. Cellipont operates in a competitive market with competitors including Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and Cell-Easy, among others.
- Headquarter Poway, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Orbimed
& 1 more
-
Employee Count
Not available
-
Acquired by
Great Point Partners
(Jan 13, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cellipont
Cellipont offers a comprehensive portfolio of products and services, including Clinical Manufacturing, Process Development, Analytical Development, and Allogeneic CAR-T Services.
Provides cGMP manufacturing for cell therapies and products
Develops processes for cell therapy production and optimization
Offers testing and analysis for cell therapy development
Specializes in manufacturing and development of CAR-T therapies
People of Cellipont
Unlock access to complete
Unlock access to complete
Funding Insights of Cellipont
Investors in Cellipont
Cellipont has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Orbimed and Great Point Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
Private equity firm focused on company buyouts
|
Locked | Locked | Locked |
Investor details for Cellipont
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cellipont
Investment portfolio details for Cellipont
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cellipont
Detailed financials for Cellipont
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellipont Comparisons
Peer comparison for Cellipont
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cellipont
Cellipont operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orgenesis, Ori Biotech, MaSTherCell, Cognate Bioservices and Cell-Easy, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cell and gene therapies for multiple disorders are developed.
|
|
| Locked | Locked | Locked |
Software development services are provided for the biopharma sector.
|
|
| Locked | Locked | Locked |
Services for cell therapy development and manufacturing are provided.
|
|
| Locked | Locked | Locked |
Development and manufacturing services for cell-based therapies are provided.
|
|
| Locked | Locked | Locked |
Stem cell-based therapy services for research solutions are provided.
|
|
| Locked | Locked | Locked |
A biotechnology company focused on anti-aging therapeutics development.
|
Detailed competitors of Cellipont
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellipont
Complete news archive for Cellipont
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellipont
Cellipont was founded in 2002 and raised its 1st funding round 21 years after it was founded.
Cellipont is headquartered in Poway, United States. It is registered at Poway, California, United States.
Cellipont was established in 2002 and is based in Poway, United States. As a contract development and manufacturing organization, focus is placed on cell therapy development services within the biotechnology sector. Operations involve supporting clients through process development, manufacturing, and regulatory guidance for cellular therapies. Services are tailored to advance therapeutic products from early stages to clinical applications, with activities centered in the U.S. market.
Cellipont's top competitors include Ori Biotech, MaSTherCell and Genflow Biosciences.
Cellipont offers Clinical Manufacturing, Process Development, Analytical Development, and Allogeneic CAR-T Services.
Cellipont has 2 investors. Key investors include Orbimed, and Great Point Partners.